Loading
RB
Response Biomedical Corp Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by ORBIMED ADVISORS LLC, was filed 20 Jun 2016.
Response Biomedical Corp: what insiders have been doing
Response Biomedical Corp is a listed company. Its directors and officers file their transactions with SEDI. The past year has been quiet: not a single insider filing for Response Biomedical Corp. The previous disclosure was published on 1 December 2016.
The full history, which starts in 2016, counts 3 purchases against no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
47
Thresholds
n/a
Buy Volume
€444,365
3 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 1 December 2016
Declarations47 total
3,604,266 sharesCommon StockSEC:0001437749-16-042830:0
34,291 sharesCommon StockSEC:0001437749-16-042830:1
2,149,902 sharesCommon StockSEC:0001437749-16-042830:2
8,259 sharesCommon StockSEC:0001437749-16-042846:0
36,764 sharesCommon StockSEC:0001437749-16-042841:0
115,379 sharesCommon StockSEC:0001437749-16-042841:1
73,850 sharesCommon StockSEC:0001437749-16-042842:0
47,500 sharesCommon StockSEC:0001437749-16-042839:0
71,396 sharesCommon StockSEC:0001437749-16-042826:0
3,604,266 sharesCommon StockSEC:0001437749-16-042826:1
34,291 sharesCommon StockSEC:0001437749-16-042826:2
2,149,902 sharesCommon StockSEC:0001437749-16-042826:3
96,884 sharesCommon StockSEC:0001437749-16-042828:0
3,604,266 sharesCommon StockSEC:0001437749-16-042828:1
34,291 sharesCommon StockSEC:0001437749-16-042828:2
2,149,902 sharesCommon StockSEC:0001437749-16-042828:3
74,742 sharesCommon StockSEC:0001437749-16-042840:0
50,154 sharesCommon StockSEC:0001437749-16-042844:0
135,671 sharesCommon StockSEC:0001437749-16-042844:1
13,541 sharesCommon SharesTSXSEDI:2856291
15,101 sharesCommon SharesTSXSEDI:2856340
56,429 sharesCommon SharesTSXSEDI:2856320
Common SharesTSXSEDI:2856338
556,339 shares@ US$0.5662.3% of flowCommon StockSEC:0000947871-16-001283:0
Canonical exit: 14 Sept 2016 (T+90)
5,294 shares@ US$0.560.6% of flowCommon StockSEC:0000947871-16-001283:1
Canonical exit: 14 Sept 2016 (T+90)
25 of 47 declarations
About Response Biomedical Corp
Response Biomedical Corp is a company focused on developing rapid diagnostic tests for disease detection. It is listed on the XTSE.
